glp 1 agonist binge eating disorder The rapid rise of GLP-1 receptor agonists presents a complex dilemma for clinicians managing patients with disorders. While these medications show potential in reducing eating behaviors by targeting brain reward Nutritional priorities to support GLP-1
Description
40.7% 2
Alongside AD, recently the efficacy of daily administration of 40 IU intranasal insulin was evaluated in PD [163]
Dennis JM, Young KG, Cardoso P, Gudemann LM, McGovern AP, Farmer A, et al
Novel GLP-1 (Glucagon-like Peptide-1) analogues and insulin in the treatment for Alzheimers disease and other neurodegenerative diseases
